Synthesis, α-glucosidase inhibitory activity, and molecular dynamic simulation of 6-chloro-2-methoxyacridine linked to triazole derivatives
- Sci Rep. 2024 Jul 28;14(1):17338. doi: 10.1038/s41598-024-68176-2.
- 1. Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran.
- 2. Department of Medicinal Chemistry, School of Pharmacy, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran.
- 3. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
- 4. Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran.
- 5. Central Research Laboratory, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran.
- 6. Department of Medicinal Chemistry, Faculty of Pharmacy, Alborz University of Medical Sciences, Karaj, Islamic Republic of Iran.
- 7. Department of Electronic Engineering, Universitat Rovira I Virgili, 43007, Tarragona, Spain.
- 8. Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
- 9. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
- 10. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
- 11. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran. [email protected].
- 12. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran. [email protected].
- 13. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran. [email protected].
Α-glucosidase inhibition can be useful in the management of carbohydrate-related diseases, especially type 2 diabetes mellitus. Therefore, in this study, a new series of 6-chloro-2-methoxyacridine bearing different aryl triazole derivatives were designed, synthesized, and evaluated as potent α-glucosidase inhibitors. The most potent derivative in this group was 7h bearing para-fluorine with IC50 values of 98.0 ± 0.3 µM compared with standard drug acarbose (IC50 value = 750.0 ± 10.5 μM). A kinetic study of compound 7h revealed that it is a competitive inhibitor against α-glucosidase. Molecular dynamic simulations of the most potent derivative were also executed and indicated suitable interactions with residues of the enzyme which rationalized the in vitro results.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: GlycosidaseResearch Areas: Metabolic Disease